The Limited Times

Now you can see non-English news...

There's a new corona vaccine: this is the country that will get it first - Walla! health

2022-01-11T05:51:51.021Z


A corona vaccine based on well-known vaccine technology was developed by two scientists in Texas, who decided they did not want to profit from it, so that it would be cheap and accessible to poor countries as well.


There is a new corona vaccine: this is the country that will get it first

A corona virus vaccine based on well-known vaccine technology was developed by two scientists in Texas, who decided they did not want to profit from it, so that it would be cheap and accessible even to poor states.

How does it work and is it effective against Omicron?

Walla!

health

11/01/2022

Tuesday, 11 January 2022, 07:40 Updated: 07:44

  • Share on Facebook

  • Share on WhatsApp

  • Share on Twitter

  • Share on Email

  • Share on general

  • Comments

    Comments

The development of the corona virus vaccine has yielded some scientists around the world very handsome profits (many billions), but there is a new vaccine in the picture and its developers do not want even a penny in return.

"We're not trying to make money. We just want people to get vaccinated," said Dr. Peter Hotz of the Center for Vaccine Development at the Texas Children's Hospital.



The corona vaccine developed by Hotz together with his colleague and research partner for years - Dr. Maria Elena Butatsi, received an emergency permit a few days ago by the Government of India. The vaccine is manufactured by a company called Biological E. Texas has two co-developers, a second-generation vaccine against Covid-19 and the company has ambitious plans to produce more than a billion vaccine doses by 2022. Hotz and Butatzi themselves will not receive any profits, but their employer - Baylor College - will be paid for it. The franchise.

More on Walla!

Yes, the corona vaccine causes a change in circulation.

Here's what's important to know about it

To the full article

Unlike Pfizer and Moderna vaccines, the Hotze and Butaci vaccine called Corbevax does not have a commercial patent, and aims to serve as a cheap and available alternative to all expensive mRNA vaccines for developing countries that still lack a sufficient supply of vaccines to vaccinate the entire population.

As mentioned, the first country to start vaccinating its citizens with the Corbevax vaccine is India, but Hotz and Butaci are already in contact with other manufacturers around the world and have also approached the World Health Organization to help them spread the vaccine they have developed in other countries around the world.

"We are not trying to make a profit, we just want people to get vaccinated."

Dr. Peter Hotz, one of the developers of the new corona vaccine approved in India (Photo: AP, John Mone)

If all goes according to plan, more manufacturers around the globe will be able to start producing the vaccine themselves, developed in Texas, based on an older technology of recombinant protein (the same technology on which the hepatitis B vaccine is based, for example).

This is a technology that many manufacturers of drugs and vaccines already know well, unlike mRNA technology which is relatively new and more complicated.



Social organizations around the world have already praised the generous move by vaccine developers and the Texas Children's Hospital under the joint sponsorship of the vaccine, saying they hope the way they work will serve as a model for how vaccines should be developed and shared globally during a global epidemic.

"If they can, why can Modern and Pfizer not?"

“The commitment of Texas Children’s Hospital to the sharing of technology it has developed challenges the pharma giant and the erroneous narrative that dictates that the development of vaccines and medical innovations thrives only under a cloak of secrecy and exclusivity. If they can do it - why should Pfizer and Modern not do the same? "Peter Maybardok, director of the Public Citizen lobbyist lobby group, told the Washington Post.



Hotz and Butatzi were able to develop their vaccine even without much help from the US government, compared to the $ 4.1 billion investment the US government made in developing the modern vaccine alone. The Corbevax vaccine was developed with only $ 7 million, mostly from private investors. For that matter, vodka maker Tito's Vodka was a local business from Austin Texas, which was one of the first to invest in the vaccine venture with a $ 1 million donation given to researchers in May 2020. "

We did not have to discuss Omicron at all, "Hotz said.

300 vaccine doses have already been ordered by the Government of India.

Vaccination in the third booster dose in Hyderabad, India (Photo: AP, Mahesh Kumar A.)

It is difficult to predict how the new vaccine will affect the disease state.

Increasing the production rate of any vaccine, even one based on well-known technology, can be a daunting challenge.

As for clinical information on the effectiveness of the vaccine - it has not been tested at all against the omicron variant that has spread in recent weeks around the world and is becoming the dominant strain of the corona virus.

So experts are following this project with skepticism.



The company that is expected to produce the vaccine in India - Biological Island.

It said it had completed two Phase 3 clinical trials involving more than 3,000 trials from across India.

In one of them, the vaccine was found to be 80 percent effective in preventing symptomatic disease, but the full data have not yet been published by the company.

And this fact leads to quite a bit of criticism.

Not tested against omicron

Joseph Osmundson, a virologist at New York University, is one of the critics concerned about the lack of public data about the third phase of the clinical trial of the Corbevax vaccine.

"These are health services for poor countries that we were never willing to accept," he said.

Hotz accepted the criticism of his colleagues with understanding, but came out in defense of the Biological Company.

Saying that this is a company of a much smaller size than the other pharma giants and that its resources are more limited.

"They assured me that they are working hard to bring the full data to publication as soon as possible. It should be remembered that this is a small company, not an international corporation," Hotz said.

Did not pass up the opportunity to sting President Biden.

Dr. Hotz and wife of President Jill Biden (Photo: AP, Justin Rex)

As of today to Biological'El.

There are already 150 million vaccine doses ready, Hotz claims, and the Indian government has already placed an order for 300 million vaccine doses.

The goal is to increase the production rate to 100 million servings per month.

Only 40 percent of India's population - eight 1.38 billion people - are fully vaccinated against the corona virus.



Officials at the company declined to comment on the cost of a vaccine dose, but the Indian media estimated that it may be a particularly low cost of about $ 2.5 per dose.

If this is true, it is one of the cheapest vaccines in the world against corona.

By comparison, Modern and Pfizer vaccine doses can sometimes cost ten times as much.

More on Walla!

  • New guidelines: This is how you will perform an antigen test for a reliable result

  • Israeli study: Babies of mothers who were vaccinated during pregnancy were born vaccinated to Corona

  • Ilan Refaeli: Our natural Israeli development to prevent hair loss has proven to be effective

What is he bragging about?

US President Joe Biden (Photo: Reuters)

A bite to Biden

Hotz and his partner Butatzi hope India is just the beginning, and there are talks to start production of their vaccine in other poor countries as well like Indonesia, Bangladesh and Botswana.

In addition, they are also in contact with the World Health Organization to share their vaccine license in the organization's open database set up to deal with the corona plague.



Hotz did not pass up the opportunity to send a sting to US President Joe Biden and other Western leaders who said they were making efforts to close the vaccine gap in third world countries. Below the Sahara, close to a billion more in Latin America and the Caribbean and another about a billion in the smaller countries of Southeast Asia.

That brings us to three billion unvaccinated. "



"We need six to nine billion vaccine doses. So you know ... When the President of the United States stood up a few weeks ago and announced that the U.S. government is the largest donor of vaccines with 275 million vaccine doses, I look at that number and think to myself: It's Not something that justifies bragging, "Hotz said.

  • health

  • news

Tags

  • Vaccine for corona

  • Corona

  • India

  • Pfizer

  • Modern

  • Vaccines

  • World Health Organization

Source: walla

All life articles on 2022-01-11

You may like

News/Politics 2024-03-16T18:46:42.470Z
News/Politics 2024-03-18T14:18:09.201Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.